Aroa Biosurgery in trading halt for capital raise

Aroa Biosurgery in trading halt for capital raise
Aroa has five products approved for sale in the US. (Image: Supplied)
Rebecca Stevenson
New Zealand headquartered medical company Aroa will raise capital to boost its presence in the US.The Australian Financial Review reported the company was seeking A$52 million to fund the expansion of its US sales team, as well as research and development.In a June market update, the soft-tissue regeneration company said US medical procedure numbers continued to reflect a positive trend “supporting improved sales momentum”.Aroa has commercial operations based in San Diego and sales professionals across the US. In its 2021 results fo...

More Markets

NZ sharemarket lifts off after Auckland Airport numbers
Markets Market close

NZ sharemarket lifts off after Auckland Airport numbers

The S&P/NZX 50 Index closed at 12,943.57, gaining 59.19 points or 0.46%.

Graham Skellern 15 Jan 2025
Auckland Airport numbers bounce back
Markets

Auckland Airport numbers bounce back

Numbers highest since the pandemic hit five years ago.

Staff reporters 15 Jan 2025
NZD outlook: 2025 more about surviving
Markets

NZD outlook: 2025 more about surviving

The kiwi shed more than 11% in 2024, and we already see more downsides. 

Rebecca Howard 15 Jan 2025
Rate decision odds are tight, NZD set for a wild ride
Markets Best of BusinessDesk

Rate decision odds are tight, NZD set for a wild ride

It did turn out to be an understatement. 

Rebecca Howard 15 Jan 2025